1990-2000 Publications

Graminski, G.F., Jayawickreme, C.K., Potenza, M.N. & Lerner, M.R.

Pigment dispersion in frog melanophores can be induced by a phorbol ester or stimulation of a recombinant receptor that activates phospholipase C. The Journal of biological chemistry268, 5957-5964 (1993).

Lerner, M.R., Potenza, M.N., Graminski, G.F., McClintock, T., Jayawickreme, C.K. & Karne, S.

A new tool for investigating G protein-coupled receptors. Ciba Foundation symposium179, 76-84; discussion 84-77 (1993).

McClintock, T.S., Graminski, G.F., Potenza, M.N., Jayawickreme, C.K., Roby-Shemkovitz, A. & Lerner, M.R.

Functional expression of recombinant G-protein-coupled receptors monitored by video imaging of pigment movement in melanophores. Analytical biochemistry209, 298-305 (1993).

Potenza, M., Bowser, R., Muller, H. & Novick, P.

SEC6 encodes an 85 kDa soluble protein required for exocytosis in yeast. Yeast8, 549-558 (1992).

Potenza, M.N. & Lerner, M.R.

A rapid quantitative bioassay for evaluating the effects of ligands upon receptors that modulate cAMP levels in a melanophore cell line. Pigment cell research / sponsored by the European Society for Pigment Cell Research and the International Pigment Cell Society5, 372-378 (1992).

Potenza, M.N. & Lerner, M.R.

A recombinant vaccinia virus infects Xenopus melanophores. Pigment cell research / sponsored by the European Society for Pigment Cell Research and the International Pigment Cell Society4, 186-192 (1991).

Potenza, M.N. & Lerner, M.R.

Characterization of a serotonin receptor endogenous to frog melanophores. Naunyn-Schmiedeberg's archives of pharmacology349, 11-19 (1994).

Potenza, M.N., Gold, S.J., Roby-Shemkowitz, A., Lerner, M.R. & Nestler, E.J.

Effects of regulators of G protein-signaling proteins on the functional response of the mu-opioid receptor in a melanophore-based assay. The Journal of pharmacology and experimental therapeutics291, 482-491 (1999).

Potenza, M.N., Graminski, G.F. & Lerner, M.R.

A method for evaluating the effects of ligands upon Gs protein-coupled receptors using a recombinant melanophore-based bioassay. Analytical biochemistry206, 315-322 (1992).

Potenza, M.N., Graminski, G.F., Schmauss, C. & Lerner, M.R.

Functional expression and characterization of human D2 and D3 dopamine receptors. The Journal of neuroscience : the official journal of the Society for Neuroscience14, 1463-1476 (1994).

Potenza, M.N., Holmes, J.P., Kanes, S.J. & McDougle, C.J.

Olanzapine treatment of children, adolescents, and adults with pervasive developmental disorders: an open-label pilot study. Journal of clinical psychopharmacology19, 37-44 (1999).

Potenza, M.N., Steinberg, M.A., McLaughlin, S.D., Rounsaville, B.J. & O'Malley, S.S.

Illegal behaviors in problem gambling: analysis of data from a gambling helpline. The journal of the American Academy of Psychiatry and the Law28, 389-403 (2000).

Rahman, Z., Gold, S.J., Potenza, M.N., Cowan, C.W., Ni, Y.G., He, W., Wensel, T.G. & Nestler, E.J.

Cloning and characterization of RGS9-2: a striatal-enriched alternatively spliced product of the RGS9 gene. The Journal of neuroscience : the official journal of the Society for Neuroscience19, 2016-2026 (1999).

Weiss, E.L., Potenza, M.N., McDougle, C.J. & Epperson, C.N.

Olanzapine addition in obsessive-compulsive disorder refractory to selective serotonin reuptake inhibitors: an open-label case series. The Journal of clinical psychiatry60, 524-527 (1999).